Global Amantadine HCl Oral Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Amantadine HCl Oral Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.
Amantadine HCl Oral report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amantadine HCl Oral market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Parkinson's Disease and Influenza are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Amantadine HCl Oral industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Amantadine HCl Oral key manufacturers include Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals and Pharmaceutical Associates, Inc. (PAI), etc. Zydus Pharmaceuticals, Mylan, Teva are top 3 players and held % sales share in total in 2022.
Amantadine HCl Oral can be divided into Tablet, Capsules and Syrup,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Amantadine HCl Oral is widely used in various fields, such as Parkinson's Disease and Influenza, etc. Parkinson's Disease provides greatest supports to the Amantadine HCl Oral industry development. In 2022, global % sales of Amantadine HCl Oral went into Parkinson's Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amantadine HCl Oral market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Zydus Pharmaceuticals
Mylan
Teva
Vertical Pharmaceuticals
Adamas Pharmaceuticals
Upsher-Smith
Sandoz
Mikart Pharmaceuticals
Pharmaceutical Associates, Inc. (PAI)
Wockhardt Bio AG
CMP Pharma
Bionpharma
Graviti Pharma
Alembic Pharmaceuticals
Strides Pharma
Heritage Pharmaceuticals
Segment by Type
Tablet
Capsules
Syrup
Parkinson's Disease
Influenza
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amantadine HCl Oral market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Amantadine HCl Oral, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Amantadine HCl Oral industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Amantadine HCl Oral in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Amantadine HCl Oral introduction, etc. Amantadine HCl Oral Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Amantadine HCl Oral market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Amantadine HCl Oral report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amantadine HCl Oral market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Parkinson's Disease and Influenza are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Amantadine HCl Oral industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Amantadine HCl Oral key manufacturers include Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals and Pharmaceutical Associates, Inc. (PAI), etc. Zydus Pharmaceuticals, Mylan, Teva are top 3 players and held % sales share in total in 2022.
Amantadine HCl Oral can be divided into Tablet, Capsules and Syrup,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Amantadine HCl Oral is widely used in various fields, such as Parkinson's Disease and Influenza, etc. Parkinson's Disease provides greatest supports to the Amantadine HCl Oral industry development. In 2022, global % sales of Amantadine HCl Oral went into Parkinson's Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amantadine HCl Oral market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Zydus Pharmaceuticals
Mylan
Teva
Vertical Pharmaceuticals
Adamas Pharmaceuticals
Upsher-Smith
Sandoz
Mikart Pharmaceuticals
Pharmaceutical Associates, Inc. (PAI)
Wockhardt Bio AG
CMP Pharma
Bionpharma
Graviti Pharma
Alembic Pharmaceuticals
Strides Pharma
Heritage Pharmaceuticals
Segment by Type
Tablet
Capsules
Syrup
Segment by Application
Parkinson's Disease
Influenza
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amantadine HCl Oral market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Amantadine HCl Oral, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Amantadine HCl Oral industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Amantadine HCl Oral in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Amantadine HCl Oral introduction, etc. Amantadine HCl Oral Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Amantadine HCl Oral market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.